Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting

2025-520566-22-00 Hormone Receptor-Positive, HER2-Negative Advanced/Metas 5 2025-11-10
Monocentric, open-label, single-arm, phase I/II clinical trial to evaluate the use of the ONCOGREEN galenic formulation consisting of indocy… Recruiting

2025-521273-14-00 Solid neoplasms of the digestive system (primary and/or 7 2025-11-10
A clinical study of sac-TMT in people with breast cancer (MK-2870-032) Recruiting

2024-520190-12-00 Breast Cancer: triple negative breast cancer (TNBC) and 5 2025-11-10
IFCT-2401 SPORADIC a multicenter randomized open label phase II study evaluating the efficacy and the tolerance of adding cemiplimab to Sequ… Recruiting

2024-517316-29-00 Unresectable stage III Non-Small Cell Lung Cancer 4 2025-11-07
A Study to Compare Vusolimogene oderparepvec (VO) Plus Nivolumab With the Doctor's Choice of Treatment in People With Skin Cancer That has G… Recruiting

2023-508612-29-00 Advanced Melanoma 5 2025-11-07
A trial to see if ficerafusp alfa given with pembrolizumab can treat participants with head and neck cancer. Recruiting

2024-519654-37-00 Recurrent or Metastatic Head and Neck Squamous Cell Car 10 2025-11-07
REDI-CaP (Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients). Innovative Management of Patients with Unfavorable Intermed… Recruiting

2025-521170-33-00 Prostate Cancer 4 2025-11-05
A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants with PD-1… Recruiting

2023-506384-34-00 Locally advanced or metastatic urothelial carcinoma 7 2025-11-05
A phase Ib/II first-in-human imaging study of anti-GD2-800CW in patients with neuroblastoma. Recruiting

2023-507596-22-00 Neuroblastoma 7 2025-11-05
TYPER Recruiting

2024-520290-12-00 Hormone receptor–positive (HRpos)/human epidermal growt 6 2025-11-04
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax P… Recruiting

2024-517131-52-00 Relapsed/Refractory Chronic Lymphocytic Leukemia/Small 5 2025-11-03
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors Recruiting

2025-521535-36-00 Locally advanced, metastatic NSCLC, CRC, or HNSCC that 1 2025-11-03
TransBronchial Needle injection of Tremelimumab in early-stage NSCLC patients (TALENT) Recruiting

2024-511878-67-00 Non small cell lung cancer 9 2025-11-03
A phase 2 placebo-controlled trial to investigate visugromab and nivolumab with or without docetaxel in second-line treatment of participant… Recruiting

2024-516794-70-00 Metastatic non-squamous non-small cell lung cancer 4 2025-11-03
A study to test how different doses of BI 1703880 in combination with ezabenlimab are tolerated in people with different types of advanced c… Recruiting

2024-511501-37-00 Advanced solid tumours 1 2025-10-31
Clinical trial evaluating the activity of zanidatamab for the treatment of patients with solid tumors with an alteration of the HER2 gene Recruiting

2025-522169-31-00 Adult Patients with HER2-IHC3+ selected solid cancers ( 4 2025-10-30
Study of encorafenib plus cetuximab as rechallenge treatment of BRAF V600E-mutant metastatic colorectal cancer patients: the RefIsh trial Recruiting

2023-509564-22-00 Patients with BRAF V600E-mutant metastatic colorectal c 4 2025-10-30
A Phase 1b/2, Study of I-DXd in Combination with Atezolizumab with or without Carboplatin in First-line ES‑SCLC Recruiting

2023-509629-36-00 Extensive-stage Small Cell Lung Cancer (ES-SCLC) 9 2025-10-29
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Recruiting

2024-514693-47-01 EGFR mutated locally advanced or metastatic non-small c 11 2025-10-28
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin i… Recruiting

2024-518365-10-00 Previously Untreated Advanced or Metastatic Non-Squamou 5 2025-10-28
OMTX705-006 Phase 1b Recruiting

2025-521872-69-00 Advanced/Metastatic Pancreatic Adenocarcinoma 3 2025-10-28
– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Profici… Recruiting

2024-519929-38-00 Metastatic Colorectal Cancer without liver metastases 4 2025-10-27
A Phase 1 Study of NDI-219216 in Patients with Advanced Solid Tumors with and without Microsatellite Instability and/or Deficient Mismatch R… Recruiting

2025-522774-36-00 Advanced solid tumors 1 2025-10-24
A trial to determine the dose, and evaluate the safety and pharmacokinetics of lutetium Lu 177 edotreotide in children with somatostatin rec… Recruiting

2024-512831-66-00 Pediatric participants aged two to less than 18 years o 3 2025-10-24